In a surprising development, Sen. Susan Collins (R-ME) took a stand against reinstating crucial medical research grants in Maine, even after advocating for their restoration with the White House. The decision has sparked significant debate and legal challenges, highlighting the complex landscape of federal funding and state interests.
The funding freeze, enacted by the Office of Management and Budget (OMB) on January 28, halted $1.5 billion in National Institutes of Health (NIH) grants. This included $323,000 earmarked for research on rural health care in Maine and $1.5 million for the Mount Desert Island Biological Lab in Bar Harbor.
Dr. Clifford Rosen expressed concerns in the Portland Press Herald, stating, “Here in Maine, we do first-class biomedical research that saves lives and produces new breakthroughs in cancer, osteoporosis, cardiovascular disease and Alzheimer’s. I can unequivocally state that loss of indirect revenues through these cuts will have a chilling effect on our Maine research enterprise.”
The freeze impacted funds directly awarded by the NIH and those appropriated by Congress. Legal battles ensued, with Maine Attorney General Aaron Frey joining a lawsuit challenging the freeze. Federal judges have since reinstated several grants, though the White House has selectively complied, creating uncertainty about the status of remaining funds.
On July 24, Collins and fellow Republicans on the Appropriations Committee urged OMB Director Russell Vought to release the Congress-approved grants in a formal letter. However, an OMB memo later suggested that these grants would only be partially restored, with new restrictions on their usage, further deepening the confusion.
Shortly thereafter, Sen. Dick Durbin (D-IL) proposed an amendment to the 2026 budget to fully reinstate the frozen funds. Despite Collins’ prior advocacy, she joined her Republican colleagues in voting against the amendment. Durbin highlighted the impact of the freeze, noting, “Nine hundred NIH awards to Northwestern have been frozen or terminated. This includes research into the world’s smallest pacemaker for newborns with a congenital heart defect. That is the number one congenital heart illness that infants face in America.”
Compounding the controversy, the Government Accountability Office ruled that the Trump administration had violated the law with its funding freeze directive.
Collins, the sole Republican senator from a state that President Trump did not carry in 2024, previously voted to confirm Vought as OMB Director, despite his involvement in Project 2025, which advocated for NIH cuts. As she eyes a sixth Senate term, Collins’ actions continue to draw scrutiny and position her as a potentially vulnerable incumbent.
The post Collins votes against restoring Maine’s NIH research grants appeared first on American Journal News.
